Achieve Life Sciences (ACHV) Operating Leases (2018 - 2025)
Achieve Life Sciences' (ACHV) quarterly Operating Leases came in at $5000.0 in Q4 2025, down 92.42% YoY from $66000.0 in Q4 2024, and down 76.19% on a QoQ basis from $21000.0 in Q3 2025.
Achieve Life Sciences (ACHV) Operating Leases (2018 - 2025) Analysis & Trends
Achieve Life Sciences (ACHV) has 8 years of Operating Leases data on file, last reported at $5000.0 in Q4 2025.
- Quarterly Operating Leases fell 92.42% year-over-year to $5000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5000.0 (down 92.42% YoY) and the FY2025 annual result came in at $5000.0, down 92.42% from the prior year.
- Operating Leases eased to $5000.0 in Q4 2025, from $21000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $69000.0 in Q4 2022 to a low of $4000.0 in Q4 2021.
- A 5-year average of $35500.0 and a median of $37500.0 in 2023 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2021 — Operating Leases slumped 94.81% — and 2022, when it soared 1625.0%.
- Tracing ACHV's Operating Leases over 5 years: stood at $4000.0 in 2021, then soared by 1625.0% to $69000.0 in 2022, then slumped by 91.3% to $6000.0 in 2023, then jumped by 1000.0% to $66000.0 in 2024, then sank by 92.42% to $5000.0 in 2025.
- The last three Operating Leases figures came in at $5000.0 (Q4 2025), $21000.0 (Q3 2025), and $37000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Dec 31, 2024 | 66,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 54,000.00 |
| Dec 31, 2022 | 69,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 23,000.00 |
| Jun 30, 2021 | 41,000.00 |
| Mar 31, 2021 | 59,000.00 |
| Dec 31, 2020 | 77,000.00 |
| Sep 30, 2020 | 94,000.00 |
| Jun 30, 2020 | 110,000.00 |
| Mar 31, 2020 | 118,000.00 |
| Dec 31, 2019 | 159,000.00 |
| Sep 30, 2019 | 212,000.00 |